MS
MRNA icon

Madden Securities’s Moderna MRNA Stock Holding History

Madden Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$54.9K Buy
+285
New +$30.7K 0.01% 195
2023
Q1 		– Sell
-570
Closed -$102K – 252
2022
Q4 		$102K Buy
+570
New +$93.2K 0.05% 130
2021
Q4 		– Sell
-2,621
Closed -$1.01M – 118
2021
Q3 		$1.01M Buy
+2,621
New +$967K 0.55% 55

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Leonteq Securities AG
Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

Madden Securities's MRNA Position: Q3 2026 in Review

Madden Securities opened a new position in Moderna (MRNA) in Q3 2026: 285 shares worth $54.9K. The stake represents 0.01% of the portfolio and ranks #195 among its holdings. This is a return to the name: Madden Securities previously reported a position in MRNA as recently as Q4 2022.

Madden Securities first reported a position in MRNA in Q3 2021 and has held it in 3 quarters since. The position peaked at $1.01M in Q3 2021. 330 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Madden Securities held 285 shares of Moderna worth $54.9K as of Q3 2026.
  • Moderna was a new Madden Securities position in Q3 2026.
  • Moderna made up 0.01% of Madden Securities's portfolio in Q3 2026, its #195 holding.
  • Madden Securities first reported a position in Moderna in Q3 2021 and has held it in 3 quarters since.
  • Madden Securities's Moderna position peaked at $1.01M in Q3 2021.
  • 330 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Madden Securities's 13F filing for Q3 2026, filed 27 Oct 2026.